Dopamine Agonist Treatment of Non-functioning Pituitary Adenomas
Dopamine Agonist Treatment of Non-functioning Pituitary Adenomas
Active, not recruiting · NCT02288962 · Registry updated 2026-07-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Dopamine Agonist Treatment of Non-functioning Pituitary Adenomas | Neoplasms by Histologic Type, Neoplasms by Site, Pituitary Neoplasms, adenoma, brain disorder, central nervous system cancer, central nervous system disorder, endocrine system disorder, epithelial neoplasm, hypothalamic disorder, hypothalamic neoplasm, malignant endocrine neoplasm, neoplasm, nervous system disorder, pituitary gland disorder, supratentorial cancer | Active, not recruiting | Phase 3 | 2026-07-21 | NCT02288962 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Norwegian University of Science and Technology | 114 |
| St. Olavs Hospital | 167 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Department of Endocrinology, Akershus University hospital | Oslo | Norway | 1 |
| Department of Endocrinology, St. Olavs Hospital | Trondheim | Norway | 1 |
| Sahlgrenska University Hospital | Gothenburg | Sweden | 96 |